Dark Horse Consulting
US-based firms like Dark Horse Consulting have built entire business models exclusively around the unique, high-risk CMC challenges of cell and gene therapies seeking FDA approval.
- Country
- United States
Commercial
CGT Focus
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| regulatory-legal | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| CMC regulatory consulting (BLA/MAA) | regulatory-legal | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.